Kringle Pharma, Inc. (4884.T)

JPY 814.0

(-0.73%)

Inventory Summary of Kringle Pharma, Inc.

  • Kringle Pharma, Inc.'s latest annual inventory in 2023 was 364.05 Million JPY , up 4.05% from previous year.
  • Kringle Pharma, Inc.'s latest quarterly inventory in 2024 Q3 was 351.49 Million JPY , down -3.44% from previous quarter.
  • Kringle Pharma, Inc. reported annual inventory of 349.87 Million JPY in 2022, up 11.04% from previous year.
  • Kringle Pharma, Inc. reported annual inventory of 315.09 Million JPY in 2021, up 579.57% from previous year.
  • Kringle Pharma, Inc. reported quarterly inventory of 351.49 Million JPY for 2024 Q3, down -3.44% from previous quarter.
  • Kringle Pharma, Inc. reported quarterly inventory of 364 Million JPY for 2024 Q2, down -0.01% from previous quarter.

Annual Inventory Chart of Kringle Pharma, Inc. (2023 - 2019)

Historical Annual Inventory of Kringle Pharma, Inc. (2023 - 2019)

Year Inventory Inventory Growth
2023 364.05 Million JPY 4.05%
2022 349.87 Million JPY 11.04%
2021 315.09 Million JPY 579.57%
2020 46.36 Million JPY 141.96%
2019 19.16 Million JPY 0.0%

Peer Inventory Comparison of Kringle Pharma, Inc.

Name Inventory Inventory Difference
KOHJIN BIO CO LTD 683.01 Million JPY 46.698%
PRISM BioLab Co.,LTD 17.92 Million JPY -1930.543%
GNI Group Ltd. 2.33 Billion JPY 84.379%
Linical Co., Ltd. - JPY -Infinity%
Trans Genic Inc. 2.22 Billion JPY 83.658%
MEDINET Co., Ltd. 67.48 Million JPY -439.494%
Soiken Holdings Inc. 1.12 Billion JPY 67.52%
Cytori Cell Research Institute, Inc. 103.53 Million JPY -251.629%
AnGes, Inc. 1.61 Billion JPY 77.469%
OncoTherapy Science, Inc. 73.99 Million JPY -391.974%
Nxera Pharma Co., Ltd. 2.9 Billion JPY 87.459%
Immuno-Biological Laboratories Co., Ltd. 321.91 Million JPY -13.091%
NanoCarrier Co., Ltd. 184 Thousand JPY -197756.522%
Carna Biosciences, Inc. 140.14 Million JPY -159.78%
CanBas Co., Ltd. 728 Thousand JPY -49907.692%
D. Western Therapeutics Institute, Inc. 87.86 Million JPY -314.345%
RaQualia Pharma Inc. 147.93 Million JPY -146.085%
Chiome Bioscience Inc. 64.1 Million JPY -467.888%
Kidswell Bio Corporation 875.65 Million JPY 58.425%
PeptiDream Inc. 2.4 Billion JPY 84.857%
Oncolys BioPharma Inc. 5.34 Million JPY -6714.976%
Ribomic Inc. 2.27 Million JPY -15909.499%
SanBio Company Limited - JPY -Infinity%
Healios K.K. - JPY -Infinity%
BrightPath Biotherapeutics Co., Ltd. 1.00 JPY -36405599900.0%
Kubota Pharmaceutical Holdings Co., Ltd. 36 Million JPY -911.267%
Delta-Fly Pharma, Inc. - JPY -Infinity%
StemRIM 29 Million JPY -1155.366%
CellSource Co., Ltd. 305.92 Million JPY -19.002%
FunPep Company Limited 25.54 Million JPY -1325.379%
Stella Pharma Corporation 1.11 Billion JPY 67.386%
TMS Co., Ltd. 50.02 Million JPY -627.748%
Noile-Immune Biotech Inc. 20.9 Million JPY -1641.811%
Cuorips Inc. 1.04 Million JPY -34804.698%
K Pharma,Inc. 10.79 Million JPY -3272.763%
Takara Bio Inc. 11.85 Billion JPY 96.928%
ReproCELL Incorporated 248.14 Million JPY -46.714%
PhoenixBio Co., Ltd. 450.58 Million JPY 19.204%
StemCell Institute Inc. 42.26 Million JPY -761.426%
Japan Tissue Engineering Co., Ltd. 228.56 Million JPY -59.279%
CellSeed Inc. 46.19 Million JPY -688.154%